a developer of transformative drugs and technologies for debilitating diseases
Industry Biotechnology
A.I.dvisor tells us that APLT and AMGXF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLT and AMGXF's prices will move in lockstep.
Ticker / NAME | Correlation To APLT | 1D Price Change % | ||
---|---|---|---|---|
APLT | 100% | -4.35% | ||
AMGXF - APLT | 32% Poorly correlated | N/A | ||
COEP - APLT | 27% Poorly correlated | +10.47% | ||
BPMC - APLT | 27% Poorly correlated | +1.14% | ||
EDIT - APLT | 25% Poorly correlated | +2.70% | ||
TRVI - APLT | 25% Poorly correlated | +6.13% | ||
More |